

* FTSE 100 down 0.2 pct, miners top losers * Shire falls on declined drug approval * Barclays rises on media report (Adds detail) By Kit Rees LONDON...


* FTSE 100 down 0.2 pct, miners top losers * Shire falls on declined drug approval * Barclays rises on media report By Kit Rees LONDON, Oct 19 (Reuter...


(ShareCast News) - Stocks moved higher at the start of trading as investors chose to focus on the positives from the raft of Chinese macroeconomic dat...


* U.S. regulator wants further lifitegrast clinical data * Shire says still planning for potential 2016 launch * Shares fall 2 pct; weakens hand in al...


(ShareCast News) - Shire has attempted to reassure the market that its lifitegrast dry-eye treatment remains on track for planned launch next year, af...